David Canes to Risk Assessment
This is a "connection" page, showing publications David Canes has written about Risk Assessment.
Connection Strength
0.185
-
Stensland KD, Morgan TM, Moinzadeh A, Lee CT, Briganti A, Catto JWF, Canes D. Considerations in the Triage of Urologic Surgeries During the COVID-19 Pandemic. Eur Urol. 2020 06; 77(6):663-666.
Score: 0.099
-
Canes D, Triaca V, Tuerk I. Laparoscopic radical cystectomy with continent urinary diversion. Curr Urol Rep. 2005 Mar; 6(2):109-17.
Score: 0.035
-
Moynihan MJ, Sullivan TB, Burks E, Schober J, Calabrese M, Fredrick A, Kalantzakos T, Warrick J, Canes D, Raman JD, Rieger-Christ K. MicroRNA profile in stage I clear cell renal cell carcinoma predicts progression to metastatic disease. Urol Oncol. 2020 10; 38(10):799.e11-799.e22.
Score: 0.025
-
Harty NJ, Kozinn SI, Canes D, Sorcini A, Moinzadeh A. Comparison of positive surgical margin rates in high risk prostate cancer: open versus minimally invasive radical prostatectomy. Int Braz J Urol. 2013 Sep-Oct; 39(5):639-46; discussion 647-8.
Score: 0.016
-
Gill IS, Canes D, Aron M, Haber GP, Goldfarb DA, Flechner S, Desai MR, Kaouk JH, Desai MM. Single port transumbilical (E-NOTES) donor nephrectomy. J Urol. 2008 Aug; 180(2):637-41; discussion 641.
Score: 0.011